And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is topped off with a visit to our oldest Pharmalot ancestor, who turns another page on the calendar, hanging with our short people, and catching up on our napping. And what about you? Once again, we will note this is a fine time to enjoy the great outdoors — apples and pumpkins are beckoning. You could read a good book or make time for someone special. And if you feel adventurous, tweet your support for the Hong Kong protesters and see what happens. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

How much members of the Sackler family should be held accountable for the role their company, Purdue Pharma, played in the opioid crisis will be at the center of a hearing Friday in federal bankruptcy court, the Associated Press informs us. State attorneys general are evenly divided over whether to accept terms offered by Purdue to settle some 2,600 claims against it. About half of them say the proposed deal is too lenient to family members who siphoned billions out of their privately held company and stashed much of it overseas.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy